GlaxoSmithKline
20 December 2024
20 Dec 2024
GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial.
GSK announces FIRST trial met its primary endpoint of progression free survival in first line advanced ovarian cancer
20 Dec 2024
GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial.
ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe
16 Dec 2024
Vocabria + Rekambys is the first and only complete long-acting regimen for the treatment of HIV, reducing dosing days from 365 to 6 per year
16 December 2024
16 Dec 2024
Positive opinion based on statistically significant and clinically meaningful progression-free and overall survival data.
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives EMA Priority Medicines (PRIME) Designation in relapsed extensive-stage small-cell lung cancer
16 Dec 2024
Regulatory designation based on promising preliminary clinical data.
Jemperli (dostarlimab) receives US FDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer
16 Dec 2024
Designation based on data showing no evidence of disease in 100% of all 42 patients who completed treatment with dostarlimab.
Jemperli (dostarlimab) plus chemotherapy receives positive CHMP opinion to expand approval to all adult patients with primary advanced or recurrent endometrial cancer
16 Dec 2024
Positive opinion based on statistically significant and clinically meaningful progression-free and overall survival data.
Blenrep shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
11 Dec 2024
DREAMM-7 trial shows sustained overall survival benefit for Blenrep (belantamab mafodotin) combination versus daratumumab combination
US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD
11 Dec 2024
Nucala could be the first approved biologic with monthly dosing for patients with COPD
Blenrep (belantamab mafodotin) combination accepted for priority review in China in relapsed/refractory multiple myeloma
11 Dec 2024
Regulatory submission supported by phase III head-to-head DREAMM-7 trial showing statistically significant efficacy.
Featured
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
How Quaker Oats grabbed customers’ attention
By Kiron Kasbekar | 07 Mar 2024
Quaker Oats, the American food products giant that was created in 1901 through the merger of many older oat millers, and was acquired by a bigger foods giant, Pepsi, in 2001, has been an innovative company. One example of its innovativeness shows in its packaging – the cereal box it launched in 1915.
Company story – Cunard Line
By Kiron Kasbekar | 12 Jan 2024
The Cunard Line started its life in Glasgow in 1839 as the British and North American Royal Mail Steam-Packet Company when Samuel Cunard was awarded the first British transatlantic steamship mail contract.
Samuel Slater – textile tycoon or traitor?
By Kiron Kasbekar | 26 Dec 2023
Samuel Slater is a name that holds significant importance in the annals of American industrial history. Often referred to as the ‘Father of the American Factory System’, Slater's contributions played a pivotal role in shaping the nation’s industrial landscape.
Underwood Typewriter Company – an icon of the past
By Kiron Kasbekar | 21 Dec 2023
You’ve probably never heard of Underwood typewriters. For the company folded up in 1963 – 60 years ago. You may not even have seen and handled a typewriter, unless someone in your family owned one.
The rise and fall of Chrysler
By Kiron Kasbekar | 16 Dec 2023
A century ago, the American automobile industry was more crowded than a vegetable market on a Sunday morning, with such a wide variety of stuff on sale that buyers were spoilt for choice. Buyers could pick and choose, bargain, pay up and drive out with the newly purchased vehicle.
TRW – the tide turned
By Kiron Kasbekar | 13 Dec 2023
There used to be an American company called Thompson Ramo Wooldridge Inc. This company, which was a global supplier of automotive systems, modules, and components to car and truck manufacturers, started small, as most companies do. Then, as the automotive industry grew bigger, so did TRW.
The rise and fall of Nokia
By Aniket Gupta | 07 Dec 2023
My interest is stories about dominant companies that failed all of a sudden. These companies were once etched into people’s minds but have since become a symbol of nostalgia. One such company, which was the biggest in its industry before it failed catastrophically, is Nokia.
Yahoo!: The first king of the internet
By Aniket Gupta | 01 Dec 2023
The year is 1994. You go to the internet to search for a particular website, but there is no Google that could be used to search your desired website. What do you do? The answer is that you use Yahoo.
.jpg)
